| 000 | 01002nam-a2200229---4500 | ||
|---|---|---|---|
| 001 | 336815 | ||
| 005 | 20200804164719.0 | ||
| 090 | _a336815 | ||
| 100 | _a20171030d2001 k y0pory5003 ba | ||
| 101 | 0 | _aeng | |
| 102 | _aDE | ||
| 200 | 1 |
_aEnabling biotechnological invention in Europe and United States _ea study of the patentability of proteins and DNA sequences with special emphasis on the disclosure requirement _fSven J. R. Boatyn |
|
| 210 |
_aMünchen _cEuropean Patent Office _dcop. 2001 |
||
| 215 |
_aXIV, 334 p. _d24 cm |
||
| 225 | 2 |
_aEposcript _fpublic. European Patent Office _vvol. 4 _x1021-9390 |
|
| 675 |
_a347.778:57.08 _vmed _zpor |
||
| 675 |
_a57.08:347.778 _vmed _zpor |
||
| 700 | 1 |
_aBoatyn, _bSven J. R., _f1967- |
|
| 712 | 0 | 2 |
_aEuropäisches Patentamt _4340 |
| 801 | 0 |
_aPT _bUMSD _c20171030 _gRPC |
|
| 942 |
_cLIVRO _n0 |
||